HSBC analyst Rajesh Kumar upgraded GlaxoSmithKline (GSK:LN) (NYSE: GSK) from Reduce to Hold with a price target of GBP18.60 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE